SEC Form 4 · accession 0000899243-17-006737
Mylan N.V. · MYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Maroon M.D.
Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 7:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Stock Option - Right to BuyF1 | $45.18 | Mar 3, 2017 | A | 2,928 | A | — | Mar 3, 2027 | Ordinary Shares | 2,928 | 2,928 | D |
| Restricted Stock UnitsF2 | $0.00 | Mar 3, 2017 | A | 3,653 | A | — | — | Ordinary Shares | 3,653 | 3,653 | D |
Explanation of responses
- F1These options will vest in full on March 3, 2018 and expire on March 3, 2027.
- F2Each restricted stock unit (RSU) represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 3, 2018.